Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Chugai licenses Roche's Hedgehog pathway inhibitor RG-3616 in Japan

Feb. 19, 2010

Thallion and LFB sign agreement to develop STEC infection therapy

Feb. 19, 2010

SurModics to terminate license agreement with Ambrilia Biopharma

Feb. 19, 2010

Paladin amends R&D agreement with Isotechnika for diagnostic products

Feb. 19, 2010

TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics

Feb. 18, 2010

MorphoSys and Galapagos add another antibody target to alliance in bone and joint diseases

Feb. 18, 2010

Lung Rx and ImmuneWorks sign development agreement for IW-001 in IPF and PGD

Feb. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...